NCT00907855View on ClinicalTrials.gov

Using Duke Activity Status Index (DASI) to Select Optimal Cardiac Stress Tests

CompletedOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

April 30, 2009

Conditions

Ischemic Heart Disease

Trial Locations (1)

10016

Nuclear Cardiology/Stress Lab, NYU Cardiology Division, New York

Sponsors

Collaborators (1)

Astellas Pharma Inc

All Listed Sponsors

collaborator

Astellas Pharma Inc

INDUSTRY

lead

NYU Langone Health

OTHER

NCT00907855 - Using Duke Activity Status Index (DASI) to Select Optimal Cardiac Stress Tests | Biotech Hunter | Biotech Hunter